Drive Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$385K Sell
2,459
-42
-2% -$6.3K 0.07% 247
2026
Q1
$382K Buy
2,501
+20
+0.8% +$3.07K 0.08% 203
2025
Q4
$342K Buy
+2,481
New +$325K 0.07% 233
2024
Q1
Sell
-2,294
Closed -$232K 336
2023
Q4
$232K Sell
2,294
-1,229
-35% -$119K 0.07% 249
2023
Q3
$359K Sell
3,523
-904
-20% -$91.8K 0.13% 148
2023
Q2
$447K Sell
4,427
-410
-8% -$41K 0.17% 124
2023
Q1
$445K Sell
4,837
-448
-8% -$39.1K 0.19% 132
2022
Q4
$480K Buy
+5,285
New +$445K 0.24% 100

Other funds holding NVS

Drive Wealth Management's NVS Position: Q2 2026 in Review

Drive Wealth Management reduced its Novartis (NVS) stake by 1.7% in Q2 2026, selling an estimated $6.3K and leaving 2,459 shares worth $385K. The position accounts for 0.07% of the portfolio, ranked #247.

Drive Wealth Management first reported a position in NVS in Q4 2022 and has held it in 8 quarters since. The position peaked at $480K in Q4 2022. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Drive Wealth Management held 2,459 shares of Novartis worth $385K as of Q2 2026.
  • Drive Wealth Management sold 42 Novartis shares in Q2 2026, an estimated $6.3K.
  • Novartis made up 0.07% of Drive Wealth Management's portfolio in Q2 2026, its #247 holding.
  • Drive Wealth Management first reported a position in Novartis in Q4 2022 and has held it in 8 quarters since.
  • Drive Wealth Management's Novartis position peaked at $480K in Q4 2022.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.